申请人:Takeda Chemical Industries, Ltd.
公开号:US04066648A1
公开(公告)日:1978-01-03
New isochroman derivatives which may be represented by general formula [I] ##STR1## wherein R.sup.1 is hydrogen atom, a lower alkoxy group or hydroxyl group and R.sup.2 is a lower alkoxy group or hydroxyl group; R.sup.1 and R.sup.2 may also be, connecting with each other, alkylenedioxy group; R.sup.3 is a hydrogen atom, a lower alkyl or aralkyl group and R.sup.4 is a lower alkyl or aralkyl group; R.sup.3 and R.sup.4 may also be groups which, taken together with the adjacent nitrogen atom, form a cyclic amino group; n means 1 or 2, and pharmacologically acceptable salt thereof have antidepressant, analgesic, diuretic, anti-inflammatory, muscle relaxing, vasodilator, hypotensive and other pharmacologic activities for mammals.
新的异色烷衍生物可用通式[I]表示,其中R1是氢原子、低级烷氧基或羟基,R2是低级烷氧基或羟基;R1和R2也可以连接在一起形成烷二氧基基团;R3是氢原子、低级烷基或芳基烷基团,R4是低级烷基或芳基烷基团;R3和R4也可以与相邻的氮原子结合形成环状氨基基团;n表示1或2,其药物学上可接受的盐对哺乳动物具有抗抑郁、镇痛、利尿、抗炎、肌肉松弛、扩张血管、降压和其他药理活性。